This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is not a best practice for inclusion in any minority supplier development ... (Read 76 times)

Collmarie

  • Hero Member
  • *****
  • Posts: 569
Which of the following is not a best practice for inclusion in any minority supplier development initiative?
 a. Ensuring that all minority suppliers are located nearby the organization's facilities.
 b. Mandating Tier 1 suppliers to have a Tier 2 diversity spend goal and incorporating the terms in the contracts.
  c. Including minority suppliers in all RFQs without exception.
 d. Tying the goals and objectives of the supplier diversity program to supply chain management strategies and supply chain job functions.
  e. Incorporating all corporate functions in which suppliers are selected and procurement commitments are made.

Question 2

A corporate __________ is the graphic representation of a company's name.
 Fill in the blank(s) with correct word



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

essyface1

  • Sr. Member
  • ****
  • Posts: 347
Answer to Question 1

a

Answer to Question 2

logo





 

Did you know?

Drugs are in development that may cure asthma and hay fever once and for all. They target leukotrienes, which are known to cause tightening of the air passages in the lungs and increase mucus productions in nasal passages.

Did you know?

The first war in which wide-scale use of anesthetics occurred was the Civil War, and 80% of all wounds were in the extremities.

Did you know?

In 1835 it was discovered that a disease of silkworms known as muscardine could be transferred from one silkworm to another, and was caused by a fungus.

Did you know?

Drying your hands with a paper towel will reduce the bacterial count on your hands by 45–60%.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library